Key Event Components

  • Key Event Components (KECs) are used to describe Key Events (KEs) in a computable way, by defining an action, processes, and object term that maps to controlled vocabulary and ontology terms.
  • KECs on this page can be filtered by the action, process, and object terms, as well as by source ontologies.
  • Link to source ontology terms are provided in cases where the URL was available when the ontology terms were added to the AOP-Wiki database.
  • A complete list of all KECs is available in TSV format on the Downloads Page.
Showing 701 to 725 of 1160 KECs
Clear Table Filters
ID Action Process Object Associated Key Events (KEs)
460 increased atrophy (MESH:D001284) olfactory epithelium (UBERON:0001997) 868: Increase, Tissue Degeneration, Necrosis & Atrophy
459 increased leukocyte mediated cytotoxicity (GO:0001909) 768: Increase, Cytotoxicity
458 decreased regulation of intracellular pH (GO:0051453) 867: Decrease, Intracellular pH
457 increased uroporphyrinogen (CHEBI:27258) 844: Oxidation, Uroporphyrinogen
456 increased porphyria (MP:0005654) 369: Uroporphyria
455 decreased catalytic activity (GO:0003824) uroporphyrinogen decarboxylase (PR:000017134) 845: Inhibition, UROD
454 increased gene expression (GO:0010467) cytochrome P450 1A5 (chicken) (PR:P79761) 850: Induction, CYP1A2/CYP1A5
453 increased gene expression (GO:0010467) cytochrome P450 1A2 (PR:000006102) 850: Induction, CYP1A2/CYP1A5
452 increased porphyrins (CHEBI:26214) 846: Accumulation, Highly carboxylated porphyrins
451 functional change lysosome (GO:0005764) 831: Disturbance, Lysosomal function
450 occurrence autophagic cell death (GO:0048102)
449 decreased phospholipase activity (GO:0004620) phospholipase A1 member A (human) (PR:Q53H76) 828: Inhibition, Phospholipase A
448 increased Microvesicular hepatic steatosis (HP:0001414) 838: Induction, Microvesicular fat
447 occurrence Mallory bodies (MP:0014045) 839: Formation, Mallory body
446 functional change Lipid bilayer of wall of lysosome (FMA:67514) 829: Damage, Lipid bilayer
445 occurrence podocyte vacuolization (MP:0011899) 824: Occurrence, Cytoplasmic vacuolization (podocyte)
444 occurrence Dilatation (MESH:D004106) renal tubule (UBERON:0009773) 823: Occurrence, Cystic dilatation (renal tubule)
443 occurrence autophagic cell death (GO:0048102) renal tubule (UBERON:0009773) 818: Occurrence, Cytoplasmic vacuolization (Renal tubule)
442 occurrence toxicity (MESH:Q000633) kidney (UBERON:0002113) 814: Occurrence, Kidney toxicity
441 increased abnormal amino acid level (MP:0005332) 813: Increased, Serum creatinine
440 increased creatinine (CHEBI:16737) 813: Increased, Serum creatinine
439 decreased function (MI:0613) kidney (UBERON:0002113) 825: Decreased, Renal ability to dilute urine
438 decreased renal absorption (GO:0070293) sodium(1+) (CHEBI:29101) 821: Decreased, Sodium reabsorption
437 decreased kidney plasma flow trait (VT:0005524) 820: Decreased, Renal plasma flow
436 decreased glomerular filtration (GO:0003094) 819: Decreased, Glomerular filtration